Valuation: Acarix AB

Market Cap 291M 30.59M 26.42M 24.83M 22.58M 42.46M 2.93B 43.16M 114M 1.46B 115M 112M 4.87B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 291M 30.59M 26.42M 24.83M 22.58M 42.46M 2.93B 43.16M 114M 1.46B 115M 112M 4.87B EV / Sales 2026 *
15.2x
EV / Sales 2027 * 4.19x
Free-Float
83.24%
Yield 2026 *
-
Yield 2027 * -
1 day-5.04%
1 week-0.41%
Current month-2.78%
1 month-2.97%
3 months-5.41%
6 months-18.33%
Current year-8.58%
1 week 0.24
Extreme 0.2415
0.27
1 month 0.23
Extreme 0.232
0.27
Current year 0.22
Extreme 0.2245
0.33
1 year 0.22
Extreme 0.2245
0.37
3 years 0.17
Extreme 0.1688
0.6
5 years 0.17
Extreme 0.1688
1.58
10 years 0.17
Extreme 0.1688
26.8
Manager TitleAgeSince
Chief Executive Officer - 2024-01-31
Chief Executive Officer 62 2018-02-22
Director TitleAgeSince
Director/Board Member 61 2019-12-31
Director/Board Member 52 2024-05-13
Director/Board Member - 2024-05-13
Change 5-day change 1-year change 3-year change Capi.($)
-5.04%-0.41%-34.14%-51.77% 30.59M
+1.02%+2.28%+20.56%-35.06% 17.1B
-2.98%+0.45%-7.31%+95.48% 1.76B
-0.44%-2.23%-27.52%+19.28% 985M
-5.24%+16.40%-44.89%-81.27% 981M
-0.05%+48.99%+71.52%-10.59% 779M
+0.95%+2.45%-35.49%-49.59% 696M
+3.92%+17.79%-34.13%-41.23% 646M
+5.89%+6.05%-40.58%-38.02% 443M
-0.99%+12.73%+41.58%+41.18% 414M
Average -0.30%+9.48%-9.04%-15.16% 2.38B
Weighted average by Cap. +0.50%+4.21%+11.53%-23.61%

Financials

2026 *2027 *
Net sales 19.1M 2.01M 1.73M 1.63M 1.48M 2.79M 192M 2.83M 7.47M 96.17M 7.54M 7.38M 320M 69.5M 7.31M 6.31M 5.93M 5.39M 10.14M 699M 10.31M 27.17M 350M 27.44M 26.84M 1.16B
Net income -28.9M -3.04M -2.62M -2.47M -2.24M -4.22M -291M -4.29M -11.3M -146M -11.41M -11.16M -484M 2.4M 252K 218K 205K 186K 350K 24.13M 356K 938K 12.08M 948K 927K 40.16M
Net Debt - -
Logo Acarix AB
Acarix AB is a Sweden-based provider of diagnostic solutions for coronary artery disease (CAD). The Company’s primary product CADScor System features phonocardiography technique and algorithms. The CADScor System is fixed with a specific patch to the chest of the patient, with the recording head placed at the forth left intercostal space, and the sensor resting on the sternum. Instructions for the procedure are given on the display for the operator and audio cues guide a patient during the two-minute heart sound recording. After recording, the CAD-score is calculated, and presented on the display of the CADScor Sensor, enabling a physicians, nurses and laboratory technicians to make a rule-out diagnosis.
Employees
8
Date Price Change Volume
26-08-14 SEK 0.2450 -5.04% 2,046,283
26-08-13 SEK 0.2580 -0.19% 1,975,029
26-08-12 SEK 0.2585 +0.78% 1,908,449
26-08-11 SEK 0.2565 +1.58% 2,219,187
26-08-10 SEK 0.2525 +2.64% 2,303,786

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ACARIX Stock